Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
复制标题
DOI:
10.1186/s13054-018-2120-z
复制
发表时间:
2018-08-18
期刊:
影响因子:
--
通讯作者:
Ozaki Y
中科院分区:
文献类型:
--
作者:
Naruse H;Ishii J;Takahashi H;Kitagawa F;Nishimura H;Kawai H;Muramatsu T;Harada M;Yamada A;Motoyama S;Matsui S;Hayashi M;Sarai M;Watanabe E;Izawa H;Ozaki Y
The early prediction of acute kidney injury (AKI) can facilitate timely intervention and prevent complications. We aimed to understand the predictive value of urinary liver-type fatty-acid binding protein (L-FABP) levels on admission to medical (non-surgical) cardiac intensive care units (CICUs) for AKI, both independently and in combination with serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels. We prospectively investigated the predictive value of L-FABP and NT-proBNP for AKI in a large, heterogeneous cohort of patients treated in medical CICUs. Baseline urinary L-FABP and serum NT-proBNP were measured on admission. AKI was diagnosed according to the Kidney Disease: Improving Global Outcomes criteria. We studied 1273 patients (mean age, 68 years), among whom 46% had acute coronary syndromes, 38% had acute decompensated heart failure, 5% had arrhythmia, 3% had pulmonary hypertension, 2% had acute aortic syndrome, 2% had infective endocarditis, and 1% had Takotsubo cardiomyopathy. Urinary L-FABP levels correlated with serum NT-proBNP levels (r = 0.17, p < 0.0001). AKI occurred in 224 patients (17.6%), including 48 patients with stage 2 or 3 disease. Patients who developed AKI had higher one-week and 6-month mortality than those who did not develop AKI (p = 0.0002 and p = 0.003, respectively). In the multivariate logistic analysis, both L-FABP (p < 0.0001) and NT-proBNP (p = 0.006) were independently associated with the development of AKI. Adding L-FABP and NT-proBNP to a baseline model that included established risk factors further improved reclassification (p < 0.001) and discrimination (p < 0.01) beyond that of the baseline model or any single biomarker individually. Urinary L-FABP and serum NT-proBNP levels on admission are independent predictors of AKI, and when used in combination, improve early prediction of AKI in patients hospitalized at medical CICUs.
登录
查看更多内容
影响因子:
5.4
作者:
Liu Y;He YT;Tan N;Chen JY;Liu YH;Yang DH;Huang SJ;Ye P;Li HL;Ran P;Duan CY;Chen SQ;Zhou YL;Chen PY
通讯作者:
Chen PY
影响因子:
24
作者:
Na, Soo Jin;Chung, Chi Ryang;Yang, Jeong Hoon
通讯作者:
Yang, Jeong Hoon
影响因子:
1.5
作者:
Maeda, Yoshiteru;Suzuki, Atsushi;Itoh, Mitsuyasu
通讯作者:
Itoh, Mitsuyasu
影响因子:
4.6
作者:
Katagiri, Daisuke;Doi, Kent;Noiri, Eisei
通讯作者:
Noiri, Eisei
DOI:
10.1053/j.ajkd.2015.10.019
发表时间:
2016-05
期刊:
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子:
--
作者:
Heung M;Steffick DE;Zivin K;Gillespie BW;Banerjee T;Hsu CY;Powe NR;Pavkov ME;Williams DE;Saran R;Shahinian VB;Centers for Disease Control and Prevention CKD Surveillance Team
通讯作者:
Centers for Disease Control and Prevention CKD Surveillance Team